Archived documents
Documents past their public comment period for Pharmaceutical Policy.
PSG_203389 - Draft Guidance on Cysteamine Bitartrate
0 comments
Analysis in progress
Top issues in comments
PSG_020392 - Draft Guidance on Cysteamine Bitartrate
0 comments
Analysis in progress
Top issues in comments
PSG_211379 - Draft Guidance on Dexamethasone
0 comments
Analysis in progress
Top issues in comments
PSG_208742 - Draft Guidance on Dexamethasone
0 comments
Analysis in progress
Top issues in comments
PSG_022122 - Draft Guidance on Diclofenac Sodium
0 comments
Analysis in progress
Top issues in comments
PSG_219876 - Draft Guidance on Dordaviprone Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_020126 - Draft Guidance on Doxepin Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_212725 - Draft Guidance on Entrectinib
0 comments
Analysis in progress
Top issues in comments
PSG_205920 - Draft Guidance on Epinephrine
0 comments
Analysis in progress
Top issues in comments
PSG_021957 - Draft Guidance on Esomeprazole Magnesium
0 comments
Analysis in progress
Top issues in comments
PSG_212102 - Draft Guidance on Fenfluramine Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_215341 - Draft Guidance on Finerenone
0 comments
Analysis in progress
Top issues in comments